Loading clinical trials...

Prophylactic Antibiotic Treatment During Vaginal Repair | Clinical Trials | Clareo Health

UNKNOWNNA

Prophylactic Antibiotic Treatment During Vaginal Repair

Antibiotikaprofylakse Ved Vaginalplastik

NCT00162604•Hvidovre University Hospital

Summary

Prolapse of the uterus, bladder and rectum is a common condition in multiparous and/or elderly women. The number of operations for vaginal repair is increasing in Denmark, but there is no consensus or evidence found about the efficiency of prophylactic antibiotics intraoperatively concerning postoperative infections. The objective of this randomized, controlled trial is to investigate the significance of prophylactic antibiotic treatment in vaginal repair operations.

Eligibility

Age

18 - No limit years

Sex

FEMALE

Healthy Volunteers

Inclusion Criteria

•Women ages 18+ with uterine prolapse grade I - II and/or cystocele and/or rectocele and/or enterocele grade I - II and/or defects of the perineal body, in whom there is medical indication for vaginal repair, but no indication for vaginal hysterectomy or transvaginal suspension of the vaginal vault after prior hysterectomy.

Exclusion Criteria

•Patients allergic to cefuroxime.
•Patients in whom a vaginal hysterectomy or a transvaginal suspension of the vaginal vault or other major surgery is planned, where prophylactic antibiotic treatment is standard.
•Patients suffering from physical or mental disorders that will not allow them to give informed consent.
•Pregnant and nursing women.

Locations (1)

Hvidovre University Hospital

Hvidovre, Denmark

Key Dates

Start Date

May 1, 2005

Last Updated

September 11, 2006

Enrollment

200

Estimated participants

Conditions

Uterine ProlapseCystoceleRectoceleEnterocele

Interventions

Cefuroxime

DRUG

Contacts

Marianne Ottesen, M.D

CONTACT

0045 36323632 marianne.8sen@dadlnet.dk

Study Comparing Transobturator Cystocele vs. Anterior Vaginal RepairS

NCT05602246

Pelvic Organ ProlapseCystocele+1 more

View study

RECRUITING

Performance of SYMMCORA® vs. V-Loc® Suture Material in Patients Undergoing Laparoscopic Total Hysterectomy

NCT06024109

Abnormal Uterine BleedingEndometriosis+6 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: September 11, 2006Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Prophylactic Antibiotic Treatment During Vaginal Repair

Inclusion Criteria

Exclusion Criteria

Study Comparing Transobturator Cystocele vs. Anterior Vaginal RepairS

Performance of SYMMCORA® vs. V-Loc® Suture Material in Patients Undergoing Laparoscopic Total Hysterectomy

Laparoscopic Pectopexy and Laparoscopic Colporrhaphies in Pelvic Organ Prolapse Treatment

Investigation to Minimize Prolapse Recurrence of the Vagina Using Estrogen

Lessons on Urethral Lidocaine in Urodynamics

Vertical Versus Horizontal Plicataion in Transperienal Repair of Rectocele